Asymptomatic myasthenia gravis influences pregnancy and birth

被引:0
作者
Hoff, J. M. [1 ]
Daltveit, A. K. [2 ,3 ]
Gilhusa, N. E. [1 ,4 ]
机构
[1] Univ Bergen, Dept Clin & Mol Med, Neurol Sect, N-5020 Bergen, Norway
[2] Univ Bergen, Med Birth Registry Norway, N-5020 Bergen, Norway
[3] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5020 Bergen, Norway
[4] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway
关键词
delivery; myasthenia gravis; pregnancy;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Women with myasthenia gravis (MG) have an increased risk of complications and adverse pregnancy outcome. This study has examined if this is true also for asymptomatic MG. Using data from the Medical Birth Registry of Norway, births of women prior to receiving an MG diagnosis or in complete clinical MG remission were compared with all non-MG births in Norway in the same period (1967-2000). Forty-nine births occurred in 37 women, 11 of them in clinical remission, and six thymectomized. The perinatal mortality was increased (P = 0.02) and induction of birth (P = 0.007) occurred more frequently. Protracted labor occurred more frequently in the target group (P = 0.03). One of the three children that died had Potter's syndrome. Both mothers with children who died were in complete clinical MG remission. One had previously given and one subsequently gave birth to a child with neonatal MG. The results indicate that complications in birth and pregnancy are not only related to clinical MG disease severity but to the underlying immunological dysfunction.
引用
收藏
页码:559 / 562
页数:4
相关论文
共 19 条
[1]   Course and treatment of myasthenia gravis during pregnancy [J].
Batocchi, AP ;
Majolini, L ;
Evoli, A ;
Lino, MM ;
Minisci, C ;
Tonali, P .
NEUROLOGY, 1999, 52 (03) :447-452
[2]  
Brueton LA, 2000, AM J MED GENET, V92, P1, DOI 10.1002/(SICI)1096-8628(20000501)92:1<1::AID-AJMG1>3.0.CO
[3]  
2-H
[4]   ABC of labour care - Induction [J].
Chamberlain, G ;
Zander, L .
BRITISH MEDICAL JOURNAL, 1999, 318 (7189) :995-998
[5]   The role of antibodies in myasthenia gravis [J].
De Baets, M ;
Stassen, MHW .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 202 (1-2) :5-11
[6]   The fetal/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn [J].
Gardnerova, M ;
Eymard, B ;
Morel, E ;
Faltin, M ;
Zajac, J ;
Sadovsky, O ;
Tripon, P ;
Domergue, M ;
VerntderGarabedian, B ;
Bach, JF .
NEUROLOGY, 1997, 48 (01) :50-54
[7]   Myasthenia gravis - Consequences for pregnancy, delivery, and the newborn [J].
Hoff, JM ;
Daltveit, AK ;
Gilhus, NE .
NEUROLOGY, 2003, 61 (10) :1362-1366
[8]   OBSTETRIC OUTCOME IN SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
LIMA, F ;
BUCHANAN, NMM ;
KHAMASHTA, MA ;
KERSLAKE, S ;
HUGHES, GRV .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 1995, 25 (03) :184-192
[9]  
Lima F, 1996, CLIN EXP RHEUMATOL, V14, P131
[10]   Infant mortality among singletons and twins in the United States during 2 decades: Effects of maternal age [J].
Misra, DP ;
Ananth, CV .
PEDIATRICS, 2002, 110 (06) :1163-1168